{"retracted":false,"update":{"timestamp":1423094400000,"doi":"10.1016/j.neulet.2014.12.023","type":"err"},"doi":"10.1016/j.neulet.2014.10.039","journal":"Neuroscience Letters","publisher":"Elsevier BV","title":"Corrigendum to “Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats” [Neurosci. Lett. 584 (2015) 276–281]"}
